Tizanidine Hydrochloride Capsule
Product Images NDC 72789-505

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine Hydrochloride (NDC 72789-505). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789505 Label (72789505)

Label for tizanidine hydrochloride 6 mg oral capsules by PD-Rx Pharmaceuticals, Inc. The label states each capsule contains 6.87 mg tizanidine hydrochloride USP equivalent to 6 mg tizanidine base. The package contains 150 capsules, marked Rx Only, with a warning that the product is not interchangeable with tizanidine tablets or Zanaflex tablets. It includes storage instructions, manufacturer details, barcode, and QR codes for prescribing information.*

FDA Label Image

Figure 1 (Tizanidine Hydrochloride Capsules Figure 1)

A line graph depicting plasma tizanidine concentration (ng/mL) versus hours from dosing (0 to 26 hours). It compares four conditions: 2x4 mg tizanidine tablets with food and without food, and 2x4 mg tizanidine capsules with food and without food, showing how concentration changes over time after dosing under these different conditions.*

FDA Label Image

Figure 2 (Tizanidine Hydrochloride Capsules Figure 2)

A line graph depicting improvement in Ashworth Score over time (hours post-dose) for three groups: 16 mg tizanidine, 8 mg tizanidine, and placebo. The x-axis shows hours post-dose from 0 to 6, and the y-axis shows improvement in Ashworth Score from 1 down to -5 with error bars. The 16 mg dose shows the greatest improvement, followed by 8 mg, and placebo shows minimal change.*

FDA Label Image

Figure 3 (Tizanidine Hydrochloride Capsules Figure 3)

A line graph comparing improvement in Ashworth Score between tizanidine (mean dose 28.8 mg) and placebo groups across three study time points: end of titration (week 3), end of maintenance (week 7), and study endpoint. Tizanidine group shows higher improvement scores with error bars indicating variability.*

FDA Label Image

Chemical Structural Formula (Tizanidine Hydrochloride Capsules Structure)

Chemical structure of tizanidine hydrochloride, showing a chlorinated benzothiazole ring attached to an imidazoline moiety, representing the active ingredient of the pharmaceutical product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.